OrganizationFirst tracked Mar 9, 2026

Recursion Pharmaceuticals

Developing AI-powered drug discovery platforms for rare genetic diseases currently.

Mention Volume1 today
6Total mentions
1Today
2Beats
Sentiment
100%
0%

From the Discourse